Methods for Making and Using Endoxifen
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 7 of these applications claim priority to application PCT/US2018/050272, filed Sep 10, 2018. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,572,334 | Methods for Making and Using Endoxifen In force · High confidence | Atossa Therapeutics, Inc. | In force | High confidence | ||
| US 11,680,036 | Methods for Making and Using Endoxifen In force · High confidence | Atossa Therapeutics, Inc. | In force | High confidence | ||
| US 12,071,391 | Methods for Making and Using Endoxifen In force · Medium confidence | Atossa Therapeutics, Inc. | In force | Medium confidence | ||
| US 12,275,684 | Methods for Making and Using Endoxifen In force · Medium confidence | Atossa Therapeutics, Inc. | In force | Medium confidence | ||
| US 12,281,056 | Methods for Making and Using Endoxifen In force · High confidence | Atossa Therapeutics, Inc. | In force | High confidence | ||
| US 12,479,790 | Methods for Making and Using Endoxifen In force · High confidence | Atossa Therapeutics, Inc. | In force | High confidence | ||
| US 11,261,151 | Methods for Making and Using Endoxifen In force · High confidence | Atossa Therapeutics, Inc. | In force | High confidence | ||
| Application 19/041,975 | Methods for Making and Using Endoxifen Pending Not granted | Atossa Therapeutics, Inc. | Pending | Not granted | ||
| Application 19/347,467 | Methods for Making and Using Endoxifen Pending Not granted | Atossa Therapeutics, Inc. | Pending | Not granted | ||
| Application 19/564,021 | Methods for Making and Using Endoxifen Pending Not granted | Atossa Therapeutics, Inc. | Pending | Not granted | ||
| 4 more patents in this group · Pro | ||||||
10 of 14 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 14.
7 of these are in force and held by Atossa Therapeutics, Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.